Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro
published in: PLOS One
date of publication: 2022-04-29
Cites articles
There is nothing here
Article - wd:Q112643565